DRUG · Mapped RxNorm record
Atezolizumab
Normalized identity: atezolizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
NCT04273061
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedInvestigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Lung Cancerverified · MONDO: lung cancer
Gastrointestinal Cancerunresolved
Genitourinary Cancerunresolved
Sarcomaverified · MONDO: sarcoma
Unknown Primary Tumorsunresolved
Skin Cancerverified · MONDO: skin cancer
Interventions
AtezolizumabDRUG · verified · RxNorm: atezolizumab
Sponsors & collaborators
British Columbia Cancer Agencylead sponsor
Hoffmann-La Rochecollaborator
BC Cancer Foundationcollaborator
Genome British Columbiacollaborator
Terry Fox Research Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04273061 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.